Cravedi Lab (@cravedilab) 's Twitter Profile
Cravedi Lab

@cravedilab

Cravedi Lab: Kidney & Immunology Research @ISMMSKidney

ID: 1102640679510069250

linkhttp://labs.icahn.mssm.edu/cravdedilab/ calendar_today04-03-2019 18:43:18

633 Tweet

468 Followers

368 Following

Edelblum Lab (@edelblumlab) 's Twitter Profile Photo

Our most recent manuscript on investigating type I #IFN induction of #TCR-dependent and -independent #antimicrobial responses in γδ IELs is now out in J Immunol. A #tweetorial of Matt Fischer's thesis work ⬇️ #gdTcells #GIresearch Lipschultz Precision Immunology Institute doi.org/10.4049/jimmun…

Cravedi Lab (@cravedilab) 's Twitter Profile Photo

JCI - ADAMTS12 promotes fibrosis by restructuring extracellular matrix to enable activation of injury-responsive fibroblasts jci.org/articles/view/…

Hans-Joachim Anders (@hjanders_hans) 's Twitter Profile Photo

Long awaited and now out in a press release. Will this significantly change the treatment landscape of LN?. Positive PIII results for Roche’s Gazyva show superiority to SOC alone in pts with LN. roche.com/media/releases…

Waggoner Lab (@labwaggoner) 's Twitter Profile Photo

Engineered novel erythropoietin receptor-IFN chimeric receptors used to uncover differential genetic determinants of type I (IFN-α/β) and type III (IFN-λ) IFN signaling Alexander Ploss JVirology Editors Aaron E Lin journals.asm.com/doi/10.1128/jv…

Engineered novel erythropoietin receptor-IFN chimeric receptors used to uncover differential genetic determinants of type I (IFN-α/β) and type III (IFN-λ) IFN signaling <a href="/PlossLab/">Alexander Ploss</a> <a href="/JVirology/">JVirology Editors</a> <a href="/Aaron_E_Lin/">Aaron E Lin</a>
journals.asm.com/doi/10.1128/jv…
Cravedi Lab (@cravedilab) 's Twitter Profile Photo

Antiviral innate immune memory in alveolar macrophages following SARS-CoV-2 infection ameliorates secondary influenza A virus disease: Immunity cell.com/immunity/fullt…

Nature Portfolio (@natureportfolio) 's Twitter Profile Photo

A paper in Nature Medicine introduces TxGNN, a graph foundation model for zero-shot drug repurposing, identifying therapeutic candidates even for diseases with limited treatment options or no existing drugs. go.nature.com/4emlcKx

A paper in <a href="/NatureMedicine/">Nature Medicine</a> introduces TxGNN, a graph foundation model for zero-shot drug repurposing, identifying therapeutic candidates even for diseases with limited treatment options or no existing drugs. go.nature.com/4emlcKx
Oded Rechavi (@odedrechavi) 's Twitter Profile Photo

Science is just better when you are free to communicate ideas in a supportive environment. This resonates so strongly with everybody here (6.8K likes already), and still we keep using horrible, slow, censoring systems for sharing scientific knowledge. We can change this.